Skip to main content

Inspection visit

Health inspection

Greene Health & Rehab CenterCMS #3956042 citations on this visit
2 citations recorded

Inspector’s narrative

What the inspector wrote

This survey cited 2 deficiencies. The full statement and the facility’s plan of correction follow, verbatim from the federal record.

395604 04/24/2025 Greene Health & Rehab Center 119 Industrial Park Road Greensburg, PA 15601
F 0755 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Some Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharmacist. Based on review of facility policies and clinical records, as well as staff interviews, it was determined that the facility failed to maintain accountability for controlled medications (drugs with the potential to be abused) for three of five residents reviewed (Residents 3, 4, 5). Findings include: The facility's policy for medication administration, dated September 26, 2024, indicated to document the administration of controlled substances in accordance with applicable law and to document necessary medication administration/treatment information (e.g., when medications are given and as needed medications) on appropriate forms. A quarterly Minimum Data Set (MDS) assessment (a mandated assessment of a resident's abilities and care needs) for Resident 3, dated February 4, 2025, revealed that the resident was cognitively intact, required assistance with care needs, had pain frequently rated a 10 of 10 on a pain scale of 0-10, was receiving an opioid (narcotic pain medication that can lead to addiction) for pain, and had diagnoses that included a fracture to the right lower leg. Physician's orders for Resident 3, dated November 27, 2024, included an order for the resident to receive 50 milligrams (mg) of Tramadol (a narcotic pain medication) every six hours as needed for moderate to severe pain rated a 7-10 on a pain scale. Review of the controlled drug record (a form that accounts for each tablet/pill/dose of a controlled drug) for Resident 3, dated February, March and April 2025 revealed that a 50 mg Tramadol tablet was signed out on February 15 at 11:03 a.m.; February 17 at 8:15 p.m.; March 2 at 9:05 p.m.; March 6 at 8:25 p.m.; March 10 at 8:03 p.m.; March 14 at 8:10 p.m.; March 15 at 9:01 p.m.; March 20 at 9:00 p.m.; April 7 at 2:50 p.m. and 8:20 p.m.; April 14 at 8:30 p.m.; April 17 at 7:45 p.m.; and April 23 at 12:35 a.m. However, there was no documented evidence in Resident 3's clinical record, including the Medication Administration Record (MAR), that the signed-out doses of controlled medications were administered to the resident on the above-mentioned dates and times. An annual MDS assessment for Resident 4, dated February 4, 2025, revealed that the resident was cognitively intact, required assistance with care needs, had pain frequently rated a 4 of 10 on a pain scale of 0-10, was receiving opioid medications for pain, and had diagnoses that included osteoarthritis, chronic pain syndrome and fibromyalgia (chronic condition causing pain in muscles and joints throughout the body). Physician's orders for Resident 4, dated December 10, 2024, included an order for the resident to Page 1 of 5 395604 395604 04/24/2025 Greene Health & Rehab Center 119 Industrial Park Road Greensburg, PA 15601
F 0755 receive 5-325 mg of oxycodone-acetaminophen (a narcotic pain medication) three times daily for pain. Level of Harm - Minimal harm or potential for actual harm Review of the controlled drug record for Resident 4, dated March 2025, revealed that a 5-325 mg oxycodone-acetaminophen tablet was signed out on March 29 at 7:30 p.m. However, there was no documented evidence in Resident 4's clinical record, including the MAR, that the signed-out dose of controlled medication was administered to the resident on the above-mentioned date and time. Residents Affected - Some A quarterly MDS assessment for Resident 5, dated March 5, 2025, revealed that the resident was cognitively intact, required assistance with care needs, had pain frequently rated a 5 of 10 on a pain scale of 0-10, was receiving opioid medications for pain, and had diagnoses that include chronic pain and polyneuropathy (disease affecting peripheral nerves in the hands, feet, arms and legs). Physician's orders for Resident 5, dated December 28, 2023, included an order for the resident to receive 5-325 mg of hydrocodone-acetaminophen (a narcotic pain medication) every four hours as needed for moderate pain. Review of the controlled drug record for Resident 5, dated February 2025, revealed that a 5-325 mg hydrocodone-acetaminophen tablet was signed out on February 25, at 2:40 a.m. However, there was no documented evidence in Resident 5's clinical record, including the MAR, that the signed-out dose of controlled medication was administered to the resident on the above-mentioned date and time. Interview with the Director of Nursing on April 24, 2025, at 3:46 p.m. confirmed that there was no documented evidence in Resident 3's, 4's and 5's clinical records to indicate that the signed-out doses of controlled medications were administered on the above-mentioned dates and times. 28 Pa. Code 211.9(a)(1) Pharmacy Services. 28 Pa. Code 211.12(d)(1)(3)(5) Nursing Services. 395604 Page 2 of 5 395604 04/24/2025 Greene Health & Rehab Center 119 Industrial Park Road Greensburg, PA 15601
F 0842 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Some Safeguard resident-identifiable information and/or maintain medical records on each resident that are in accordance with accepted professional standards. Based on a review of clinical records, as well as resident and staff interviews, it was determined that the facility failed to maintain clinical records that were complete and accurately documented for five of five residents reviewed (Residents 1, 2, 3, 4, 5). Findings include: The facility's policy for medication administration, dated September 26, 2024, indicated to document the administration of controlled substances (drugs with the potential to be abused) in accordance with applicable law and to document necessary medication administration/treatment information (e.g., when medications are given and as needed medications) on appropriate forms. An annual Minimum Data Set (MDS) assessment (a mandated assessment of a resident's abilities and care needs) for Resident 1, dated April 9, 2025, revealed that the resident was cognitively intact, required assistance with care needs, was receiving a scheduled opioid (narcotic pain medication that can lead to addiction) for pain, and had diagnoses that included multiple sclerosis (MS-chronic disease that affects nerves in the brain and spinal cord) and chronic pain. Physician's orders for Resident 1, dated September 18, 2024, included an order for the resident to receive 50 milligrams (mg) of Tramadol (a narcotic pain medication) every four hours and to hold for sedation and document. A review of the Medication Administration Record (MAR) for Resident 1, dated February and March 2025, revealed that 50 mg of Tramadol was administered to the resident on February 8 at 4:00 p.m. and 8:00 p.m.; February 9 at 12:00 a.m. and 4:00 a.m.; February 25 at 4:00 a.m.; March 28 at 8:00 p.m.; and March 29 at 12:00 a.m. However, a review of the resident's controlled medication record (a form that accounts for each tablet/pill/dose of a controlled drug), dated February and March 2025, revealed no documented evidence that 50 mg of Tramadol was signed out for administration on the above-mentioned dates and times. A quarterly MDS assessment for Resident 2, dated February 12, 2025, revealed that the resident was cognitively intact, required assistance with care needs, had pain rated a 5 of 10 on a pain scale of 0-10, was receiving opioid medications for pain, and had diagnoses that included polyneuropathy (disease affecting peripheral nerves in the hands, feet, arms and legs) and spinal stenosis (condition where the spaces within the spine narrow). Physician's orders for Resident 2, dated April 4, 2025, included an order for the resident to receive 50 mg of Tramadol every six hours. A review of the MAR for Resident 2, dated April 2025, revealed that 50 mg of Tramadol was administered to the resident on April 5, at 12:00 a.m. However, a review of the resident's controlled medication record, dated April 2025, revealed no documented evidence that 50 mg of Tramadol was signed out for administration on the above-mentioned date and time. A quarterly MDS assessment for Resident 3, dated February 4, 2025, revealed that the resident was cognitively intact, required assistance with care needs, had pain frequently rated a 10 of 10 on a pain scale of 0-10, was receiving opioid medications for pain, and had diagnoses that included a 395604 Page 3 of 5 395604 04/24/2025 Greene Health & Rehab Center 119 Industrial Park Road Greensburg, PA 15601
F 0842 fracture to the right lower leg. Level of Harm - Minimal harm or potential for actual harm Physician's orders for Resident 3, dated November 27, 2024, included an order for the resident to receive 50 mg of Tramadol every six hours as needed for moderate to severe pain rated a 7-10 on a pain scale. Residents Affected - Some A review of the MAR for Resident 3, dated February and April 2025 revealed that 50 mg of Tramadol was administered to the resident on February 18 at 1:19 a.m. and April 22 at 9:08 p.m. However, a review of the resident's controlled medication record, dated February and April 2025, revealed no documented evidence that 50 mg of Tramadol was signed out for administration on the above-mentioned dates and times. An annual MDS assessment for Resident 4, dated February 4, 2025, revealed that the resident was cognitively intact, required assistance with care needs, had pain frequently rated a 4 of 10 on a pain scale of 0-10, was receiving opioid medications for pain, and had diagnoses that included osteoarthritis, chronic pain syndrome, and fibromyalgia (chronic condition causing pain in muscles and joints throughout the body). Physician's orders for Resident 4, dated December 10, 2024, included an order for the resident to receive 5-325 mg of oxycodone-acetaminophen (a narcotic pain medication) three times daily for pain. A review of the MAR for Resident 4, dated February 2025, revealed that 5-325 mg of oxycodone-acetaminophen was administered to the resident on February 8, at 2:00 p.m. However, a review of the resident's controlled medication record, dated February 2025, revealed no documented evidence that 5-325 mg of oxycodone-acetaminophen was signed out for administration on the above-mentioned date and time. Physician's orders for Resident 4, dated April 2, 2025, included an order for the resident to receive 7.5 mg of oxycodone (a narcotic pain medication) every six hours. A review of the MAR for Resident 4, dated April 2025, revealed that 7.5 mg of oxycodone was administered to the resident on April 22 at 12:00 p.m. and 6:00 p.m., and April 23 at 12:00 a.m. However, a review of the resident's controlled medication record, dated April 2025, revealed no documented evidence that 7.5 mg of oxycodone was signed out for administration on the above-mentioned dates and times. A quarterly MDS assessment for Resident 5, dated March 5, 2025, revealed that the resident was cognitively intact, required assistance with care needs, had pain frequently rated a 5 of 10 on a pain scale of 0-10, was receiving opioid medications for pain, and had diagnoses that include chronic pain and polyneuropathy, Physician's orders for Resident 5, dated December 27, 2023, included an order for the resident to receive 5-325 mg of hydrocodone-acetaminophen (a narcotic pain medication) twice daily for chronic pain. A review of the MAR for Resident 5, dated March 2025, revealed that 5-325 mg of hydrocodone-acetaminophen was administered to the resident on March 31 at bedtime. However, a review of the resident's controlled medication record, dated March 2025, revealed no documented evidence that 5-325 mg of hydrocodone-acetaminophen was signed out for administration on the above-mentioned date and time. 395604 Page 4 of 5 395604 04/24/2025 Greene Health & Rehab Center 119 Industrial Park Road Greensburg, PA 15601
F 0842 Level of Harm - Minimal harm or potential for actual harm Interview with the Director of Nursing on April 24, 2025, at 3:46 p.m. confirmed that there was no documented evidence that the above-mentioned medications were signed out for administration on the controlled medication sheets for Residents 1, 2, 3, 4, and 5 on the above-mentioned dates and times. 28 Pa Code 211.5(f) Clinical Records. Residents Affected - Some 28 Pa. Code 211.12(d)(5) Nursing Services. 395604 Page 5 of 5

Reading this as a family member? Your long-term care ombudsman is a free advocate for residents and families.

Back to top

Citations

2 citations recorded*CMS

What do CMS severity letters mean?

Serious (G-L). Actual harm to a resident, or immediate jeopardy. Codes G through I indicate actual harm; J through L indicate immediate jeopardy to resident health or safety.

General (A-F). No actual harm found, or harm that is minimal. The facility must still submit a Plan of Correction. Most CMS citations land here.

Each letter combines severity with scope: how many residents the deficiency affected.

  • 0755GeneralS&S Epotential for harm

    F755 - Pharmacy Services

    Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharmacist.

  • 0842GeneralS&S Epotential for harm

    F842 - Resident-identifiable information

    Safeguard resident-identifiable information and/or maintain medical records on each resident that are in accordance with accepted professional standards.

FAQ · About this visit

Common questions about this visit

What happened during the April 24, 2025 survey of Greene Health & Rehab Center?

This was a inspection survey of Greene Health & Rehab Center on April 24, 2025. The surveyor cited 2 deficiencies, recorded on the federal Form 2567 statement of deficiencies.

Were any deficiencies cited at Greene Health & Rehab Center on April 24, 2025?

Yes, 2 deficiencies were cited, each with a CMS Scope and Severity grade. The first was: "Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharm..."

What type of survey was this?

This was a inspection survey conducted by state surveyors under federal Centers for Medicare & Medicaid Services (CMS) oversight. Findings are published on CMS Care Compare.

Share this reportEmail

Next steps

Concerned about a resident’s care?Find your local ombudsman through the Eldercare Locatoror file a complaint with your state survey agency.

Researching this visit professionally?Book a 15-minute calland we will walk through what we have on file.

Data from CMS Care Compare public records. Dataset last refreshed . If you believe any information is inaccurate, report it here.